Bencherif Merouane 4
4 · TARGACEPT INC · Filed May 22, 2012
Insider Transaction Report
Form 4
TARGACEPT INCTRGT
Bencherif Merouane
VP, Preclinical Research
Transactions
- Exercise/Conversion
Common Stock
2012-05-18$2.93/sh+15,938$46,698→ 15,938 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-05-18−15,938→ 7,970 totalExercise: $2.93Exp: 2019-01-08→ Common Stock (15,938 underlying)
Footnotes (1)
- [F1]This option vested (vests) in equal installments on the last day of 16 consecutive calendar quarters begininng with March 31, 2009.